TP53 and cancer: Specific inhibition of autophagy or JNK can potentiate the re-sensitization of these resistant cancer cells to 5-FU and significantly enhance 5-FU-induced apoptosis, implying that JNK activation confers 5-FU resistance in HCT116 p53−/− and HT29 cells by inducing survival autophagy.